Craniofacial Features of POLR3-related Leukodystrophy Caused by Biallelic Variants in , and
Overview
Authors
Affiliations
Background: RNA polymerase III-related or 4H leukodystrophy (POLR3-HLD) is an autosomal recessive hypomyelinating leukodystrophy characterized by neurological dysfunction, hypodontia and hypogonadotropic hypogonadism. The disease is caused by biallelic pathogenic variants in , , or . Craniofacial abnormalities reminiscent of Treacher Collins syndrome have been originally described in patients with POLR3-HLD caused by biallelic pathogenic variants in . To date, no published studies have appraised in detail the craniofacial features of patients with POLR3-HLD. In this work, the specific craniofacial characteristics of patients with POLR3-HLD associated with biallelic pathogenic variants in , and are described.
Methods: The craniofacial features of 31 patients with POLR3-HLD were evaluated, and potential genotype-phenotype associations were evaluated.
Results: Various craniofacial abnormalities were recognized in this patient cohort, with each individual presenting at least one craniofacial abnormality. The most frequently identified features included a flat midface (61.3%), a smooth philtrum (58.0%) and a pointed chin (51.6%). In patients with biallelic variants, a thin upper lip was frequent. Craniofacial anomalies involving the forehead were most commonly associated with biallelic variants in and while a higher proportion of patients with biallelic variants demonstrated bitemporal narrowing.
Conclusion: Through this study, we demonstrated that craniofacial abnormalities are common in patients with POLR3-HLD. This report describes in detail the dysmorphic features of POLR3-HLD associated with biallelic variants in , and .
Liu J, Niu Y, Qin J, Yang Z Front Neurol. 2024; 15:1355484.
PMID: 38550343 PMC: 10972892. DOI: 10.3389/fneur.2024.1355484.
Macintosh J, Perrier S, Pinard M, Tran L, Guerrero K, Prasad C Front Neurol. 2023; 14:1254140.
PMID: 37915380 PMC: 10616956. DOI: 10.3389/fneur.2023.1254140.